Literature DB >> 3729632

Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases.

J Rubin, R Ball.   

Abstract

Eight patients with severe heart failure and renal insufficiency whose conditions were refractory to diuretics were treated by continuous ambulatory peritoneal dialysis. Seven of the eight patients died. Although the patients no longer had uncontrolled congestive heart failure, hospitalization rates failed to improve due to dialysis complications and underlying heart disease. The one long-term survivor was being treated with diuretics alone after peritoneal dialysis was used to control heart failure. Although survival was short after initiation of dialysis (median survival, 225 days), this therapy may merit further study in patients less ill.

Entities:  

Mesh:

Year:  1986        PMID: 3729632

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide.

Authors:  T P Dormans; R M Huige; P G Gerlag
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

Review 2.  Combination diuretic therapy in severe congestive heart failure.

Authors:  T P Dormans; P G Gerlag; F G Russel; P Smits
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

Review 3.  Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective.

Authors:  Masaaki Nakayama
Journal:  Perit Dial Int       Date:  2013 Jan-Feb       Impact factor: 1.756

4.  Peritoneal ultrafiltration in end-stage chronic heart failure.

Authors:  Hanna Fröhlich; Hugo A Katus; Tobias Täger; Nicole Lossnitzer; Leonie Grossekettler; Lars Kihm; Martin Zeier; Andrew Remppis; Lutz Frankenstein; Vedat Schwenger
Journal:  Clin Kidney J       Date:  2015-02-17

Review 5.  Kidney Replacement Therapy in Cardiorenal Syndromes.

Authors:  Daniel Patschan; Kim Drubel; Igor Matyukhin; Benedikt Marahrens; Susann Patschan; Oliver Ritter
Journal:  J Clin Med Res       Date:  2022-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.